Boehringer files for new rare disease use for nintedanib in EU, USBoehringer Ingelheim has filed for a new use for its lung drug nintedanib in the US and Europe, Share XBoehringer files for new rare disease use for nintedanib in EU, UShttps://pharmaphorum.com/news/boehringer-files-for-new-rare-disease-use-for-nintedanib-in-eu-us/
